The role of prostate needle biopsy in evaluation of chemopreventive agents

Urology

Volumn 57, Issue 4 SUPPL. 1, 2001, Pages 191-193

  Marks, Leonard S ^a,c   Epstein, Jonathan I ^b   Partin, Alan W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; HUMAN; MALE; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ANTICARCINOGENIC AGENTS; BIOPSY, NEEDLE; HUMANS; MALE; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 0035316053     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(00)00972-9     Document Type: Article

References (20)

1. Kamat AM, and Lamm DL: Chemoprevention of urological cancer. J Urol 161: 1748-1760, 1999.
2. Hodge KK, McNeal JE, Terris MK, and Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71-74, 1989.
3. Desmond PM, Clark J, Thompson IM, et al: Morbidity with contemporary prostate biopsy. J Urol 150: 1425-1426, 1993.
4. Rietbergen JB, Kruger AE, Kranse R, and Schroder FH: Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 49: 875-880, 1997.
5. Hammerer P, and Huland H: Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151:99-102, 1994.
6. Naughton CK, Ornstein DK, Smith DS, and Catalona WJ: Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol 163: 168-171, 2000.
7. Marks LS, Partin AW, Dorey FJ, et al: Long-term effects of finasteride on prostate tissue composition. Urology 53: 574-580, 1999.
8. Marks LS, Partin AW, Epstein JI, et al: Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol 163: 1451-1456.
9. Chon JK, Borkowski A, Partin AW, et al: Alpha l-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol 161: 2002-2008, 1999.
10. Epstein JI, Partin AW, Shue M, et al: Histological changes in benign prostate biopsies following long-term, finasteride therapy for benign prostatic hyperplasia. J Urol Pathol 10: 87-95, 1999.
11. Marks LS, Partin AW, Gormley GJ, et al: Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. J Urol 157: 2171-2178, 1997.
12. Iczkowski KA, and Bostwick DG: Prostate biopsy 1999: strategies and significance of pathological findings. Semin Urol Oncol 17: 177-186, 1999.
13. Eskew LA, Bare RL, and McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157: 199-202, 1997.
14. Chang JJ, Shinohara K, Bhargava V, and Presti JC: Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160: 2111-2114, 1998.
15. Presti JC Jr, Chang JJ, Bhargava V, and Shinohara K: The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163: 163-166, 2000.
16. Kelloff GJ, Lieberman R, and Steele VE, et al: Chemoprevention of prostate cancer: concepts and strategies. Eur Urol 35: 342-350, 1999.
17. Thompson IM, Coltman CA Jr, and Crowley J: Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial. Prostate 33: 217-221, 1997.
18. Partin AW, and Marks LS: Prostate specific antigen and new serum biomarkers for evaluation of chemopreventive agents. Urology 57(4A): 132-136, 2001.
19. Bostwick DG: Prostatic intraepithelial neoplasia is a risk factor for cancer. Semin Urol Oncol 17: 187-198, 1999.
20. Steinberg DM, Sauvageot J, Piantadosi S, Epstein JI: Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21: 566-576, 1997.